慢性及终末期肾病患者CABG术中手术策略改变
基于多中心前瞻性REQUEST注册研究的回顾性比较,95例慢性及终末期肾病患者与921例肾功能正常患者接受CABG,采用术中高频超声和TTFM方案。慢性及终末期肾病患者总体手术策略改变率更高(33.7% vs 24.3%;OR=1.58;95%CI=1.01-2.48;P=0.047),每移植物修正率更高(7.0% vs 3.4%;OR=2.14;95%CI=1.17-3.71;P=0.008),但最终鱼精蛋白后移植物TTFM参数相当。
要点
- 慢性及终末期肾病患者CABG术中手术策略改变率显著高于肾功能正常者。
- 每移植物修正率在肾病患者中更高,但最终移植物血流参数相当。
- 术中高频超声联合TTFM方案有助于识别需策略调整的肾病CABG患者。
核心结论
- 慢性及终末期肾病患者接受CABG时,术中手术策略改变和移植物修正更频繁,但最终移植物血流与肾功能正常者相当。
研究设计与样本
- 多中心前瞻性REQUEST注册研究的回顾性比较,纳入95例慢性及终末期肾病患者和921例肾功能正常患者,均按术中高频超声和TTFM方案行CABG。
主要发现
- 慢性及终末期肾病患者总体手术策略改变率为33.7%,肾功能正常者为24.3%(OR=1.58;95%CI=1.01-2.48;P=0.047)。
- 慢性及终末期肾病患者每移植物修正率为7.0%,肾功能正常者为3.4%(OR=2.14;95%CI=1.17-3.71;P=0.008)。
- 两组最终鱼精蛋白后移植物TTFM参数相当。
临床怎么用
- 对慢性及终末期肾病患者行CABG时,应预期更高的术中策略改变和移植物修正需求,并采用高频超声联合TTFM进行术中评估。
局限性
- 本研究为回顾性比较,可能受混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Factors such as more diffuse atherosclerosis, plaque instability and accelerated vascular calcification in patients with chronic and end-stage renal disease (ESRD) can potentially present intraoperative challenges in coronary artery bypass grafting (CABG) procedures. We evaluated whether patients with chronic and ESRD experienced more surgical strategy changes and/or graft revisions than patients with normal renal function when undergoing CABG procedures according to a protocol for intraoperative high-frequency ultrasound and transit-time flow measurement (TTFM). METHODS: Outcomes of CABG for patients with chronic and ESRD and patients with normal renal function enrolled in the multicentre prospective REQUEST (REgistry for QUality assESsmenT with Ultrasound Imaging and TTFM in Cardiac Bypass Surgery) study were compared retrospectively. The primary end point was frequency of intraoperative surgical strategy changes. The secondary end point was post-protamine TTFM parameters. RESULTS: There were 95 patients with chronic and ESRD and 921 patients with normal renal function. Patients with chronic and ESRD undergoing CABG according to a protocol for intraoperative high-frequency ultrasound and TTFM had a higher rate of strategy changes overall [33.7% vs 24.3%; odds ratio (OR) = 1.58; 95% confidence interval (CI) = 1.01-2.48; P = 0.047] and greater revisions per graft (7.0% vs 3.4%; odds ratio = 2.14; 95% CI = 1.17-3.71; P = 0.008) compared to patients with normal renal function. Final post-protamine graft TTFM parameters were comparable between cohorts. CONCLUSIONS: Patients with chronic and ESRD undergoing CABG procedures with high-frequency ultrasound and TTFM experience more surgical strategy changes than patients with normal renal function while achieving comparable graft flow. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT02385344.
引用
- Rosenfeld ES, Trachiotis GD, Sparks AD, et al. Intraoperative surgical strategy changes in patients with chronic and end-stage renal disease undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2021. PMID: 33675642. doi:10.1093/ejcts/ezab104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。